Novel anti-IGF-IR antibodies and uses thereof

Details for Australian Patent Application No. 2011236042 (hide)

Owner Pierre Fabre Medicament

Inventors Corvaia, Nathalie; Goetsch, Liliane

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011236042

Parent 2005268505

Filing date 14 October 2011

Wipo publication date 3 November 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/18 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Murine cells, e.g. mouse cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

3 November 2011 Application Open to Public Inspection

  Published as AU-A-2011236042

3 November 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011236043-Safety systems for power equipment

2011236041-Thick walled composite tubular and method of making